Clinical Significance of TROAP in Endometrial Cancer and the Antiproliferative and Proapoptotic Effects of TROAP Knockdown in Endometrial Cancer Cells: Integrated Utilization of Bioinformatic Analysis and in Vitro Test Verification

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2024 Jul 5

PMID 38967825

Authors

Yan Qiao

Zheng Chen

Wei Li

Hongliang Li

Liqing Zhou

Affiliations

Soon will be listed here.

Abstract

Trophinin-associated protein (TROAP), a cytoplasmic protein essential for spindle assembly and centrosome integrity during mitosis, has been reported to serve as an oncogene in various tumors. However, its role in endometrial cancer (EC) progression is still undefined. TROAP expression in EC was analyzed via GEPIA and HPA databases. The diagnostic and prognostic values of TROAP were examined by ROC curve analysis and Kaplan-Meier plotter, respectively. Cell proliferation was evaluated using CCK-8 and EdU incorporation assays. Apoptosis was assessed using TUNEL and flow cytometry assays. GSEA was performed to explore TROAP-related pathways in EC. Expression of TROAP, proliferating cell nuclear antigen (PCNA), Ki-67, cleaved-caspase-3 (cl-caspase-3), caspase-3, active β-catenin, and total β-catenin was detected using western blot analysis. TROAP was upregulated in EC. TROAP served as a potential diagnostic and prognostic marker in EC patients. TROAP silencing suppressed proliferation and enhanced apoptosis in EC cells. GSEA revealed that EC and Wnt signaling pathways were related to the expression of TROAP. We further demonstrated that TROAP knockout repressed the Wnt/β-catenin pathway in EC cells. Moreover, SKL2001, a Wnt/β-catenin activator, partially abrogated the effects of TROAP silencing on EC cell proliferation and apoptosis, while the signaling inhibitor XAV-939 had the opposite effect. In conclusion, TROAP knockout retarded proliferation and elicited apoptosis in EC cells by blocking the Wnt/β-catenin pathway.

References

Cai L, Wang H, Yang Q . CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma. Oncol Lett. 2017; 13(1):51-56. PMC: 5245097. DOI: 10.3892/ol.2016.5394. View

Dellinger T, Planutis K, Tewari K, Holcombe R . Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Rev Anticancer Ther. 2011; 12(1):51-62. DOI: 10.1586/era.11.194. View

Fukuda M, Nozawa S . Trophinin, tastin, and bystin: a complex mediating unique attachment between trophoblastic and endometrial epithelial cells at their respective apical cell membranes. Semin Reprod Endocrinol. 2000; 17(3):229-34. DOI: 10.1055/s-2007-1016230. View

Fukuda M, Sugihara K . Trophinin in cell adhesion and signal transduction. Front Biosci (Elite Ed). 2011; 4(1):342-50. DOI: 10.2741/381. View

Fukuda M, Sato T, Nakayama J, Klier G, Mikami M, Aoki D . Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation. Genes Dev. 1995; 9(10):1199-210. DOI: 10.1101/gad.9.10.1199. View

Gyorffy B, Lanczky A, Szallasi Z . Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 2012; 19(2):197-208. DOI: 10.1530/ERC-11-0329. View

Harada O, Suga T, Suzuki T, Nakamoto K, Kobayashi M, Nomiyama T . The role of trophinin, an adhesion molecule unique to human trophoblasts, in progression of colorectal cancer. Int J Cancer. 2007; 121(5):1072-8. DOI: 10.1002/ijc.22821. View

Hu H, Xu L, Chen Y, Luo S, Wu Y, Xu S . The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma. J Cancer. 2019; 10(4):957-967. PMC: 6400818. DOI: 10.7150/jca.26666. View

Jiao Y, Li Y, Lu Z, Liu Y . High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer. Dig Dis Sci. 2018; 64(1):137-143. DOI: 10.1007/s10620-018-5315-x. View

10.

Jin L, Zhou Y, Chen G, Dai G, Fu K, Yang D . EZH2-TROAP Pathway Promotes Prostate Cancer Progression TWIST Signals. Front Oncol. 2021; 10:592239. PMC: 7938320. DOI: 10.3389/fonc.2020.592239. View

11.

Jing K, Mao Q, Ma P . Decreased expression of TROAP suppresses cellular proliferation, migration and invasion in gastric cancer. Mol Med Rep. 2018; 18(3):3020-3026. DOI: 10.3892/mmr.2018.9230. View

12.

Lee Y, Lheureux S, Oza A . Treatment strategies for endometrial cancer: current practice and perspective. Curr Opin Obstet Gynecol. 2016; 29(1):47-58. DOI: 10.1097/GCO.0000000000000338. View

13.

Li K, Zhang R, Wei M, Zhao L, Wang Y, Feng X . TROAP Promotes Breast Cancer Proliferation and Metastasis. Biomed Res Int. 2019; 2019:6140951. PMC: 6526557. DOI: 10.1155/2019/6140951. View

14.

Li L, Wei J, Song Y, Fang S, Du Y, Li Z . TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression. Cell Death Dis. 2021; 12(1):125. PMC: 7838256. DOI: 10.1038/s41419-021-03422-3. View

15.

Moon R, Kohn A, De Ferrari G, Kaykas A . WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004; 5(9):691-701. DOI: 10.1038/nrg1427. View

16.

Morin P . beta-catenin signaling and cancer. Bioessays. 1999; 21(12):1021-30. DOI: 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P. View

17.

Nadano D, Nakayama J, Matsuzawa S, Sato T, Matsuda T, Fukuda M . Human tastin, a proline-rich cytoplasmic protein, associates with the microtubular cytoskeleton. Biochem J. 2002; 364(Pt 3):669-77. PMC: 1222615. DOI: 10.1042/BJ20011836. View

18.

Prat J, Mutch D . Pathology of cancers of the female genital tract including molecular pathology. Int J Gynaecol Obstet. 2018; 143 Suppl 2:93-108. DOI: 10.1002/ijgo.12617. View

19.

Ray M, Fleming G . Management of advanced-stage and recurrent endometrial cancer. Semin Oncol. 2009; 36(2):145-54. DOI: 10.1053/j.seminoncol.2008.12.006. View

20.

Ryan N, Glaire M, Blake D, Cabrera-Dandy M, Evans D, Crosbie E . The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genet Med. 2019; 21(10):2167-2180. PMC: 8076013. DOI: 10.1038/s41436-019-0536-8. View